Brooks Laboratories Ltd (BROOKS) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Brooks Laboratories Ltd reported sales of ₹22.96 Cr, operating profit of ₹-1.34 Cr (OPM -5.84%) and net profit of ₹-1.79 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
BROOKS quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 20.79 20.52 23.32 25.51 23.45 16.57 20.21 22.96 Expenses 24.2 22.02 24.58 22.38 20.93 15.84 19.53 24.3 Operating Profit -3.41 -1.5 -1.26 3.13 2.52 0.73 0.68 -1.34 OPM -16.4% -7.31% -5.4% 12.27% 10.75% 4.41% 3.36% -5.84% Other Income 0.2 0.03 0.62 7.15 6.13 5.32 1.35 0.18 Interest 0.32 0.28 0.26 0.3 0.28 0.16 0.09 0.21 Depreciation 0.43 0.38 0.39 0.39 0.39 0.39 0.41 0.42 Profit before tax -3.96 -2.13 -1.29 9.59 7.98 5.5 1.53 -1.79 Tax 0% 0% 13.95% 0% 0% 0% 0% 0% Net Profit -3.96 -2.13 -1.46 9.58 7.98 5.5 1.52 -1.79 EPS in Rs -1.51 -0.81 -0.5 3.25 2.71 1.87 0.52 -0.61
BROOKS profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 91 63 79 83 86 83 Expenses 105 93 97 91 79 81 Operating Profit -14 -30 -18 -8 7 3 OPM -16% -47% -22% -10% 8% 3.1% Other Income 1 1 1 1 20 13 Interest 3 2 1 1 1 1 Depreciation 7 7 2 2 2 2 Profit before tax -24 -38 -20 -10 25 13 Tax -19% -19% 0% 2% 0% - Net Profit -19 -31 -20 -10 25 13 EPS in Rs -4.31 -7.97 -7.46 -3.38 8.34 4.49 Dividend Payout 0% 0% 0% 0% 0% -
BROOKS balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 25 26 29 29 29 Reserves 49 39 69 86 93 Borrowings 7 6 8 8 9 Other Liabilities 29 19 18 16 17 Total Liabilities 110 90 124 140 148 Fixed Assets 15 14 14 13 15 CWIP 0 0 0 1 1 Investments 64 43 74 86 92 Other Assets 31 34 36 40 40 Total Assets 110 90 124 140 148
BROOKS cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity -37 -14 -10 3 9 Cash from Investing Activity -25 0 0 -45 -3 Cash from Financing Activity 64 11 10 42 0 Net Cash Flow 2 -3 0 0 7 Free Cash Flow -62 -15 -10 2 6 CFO/OP 261% 48% 56% -26% 131%
BROOKS ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 71 74 75 88 69 Inventory Days 157 80 60 61 77 Days Payable 159 165 97 90 80 Cash Conversion Cycle 68 -12 38 59 66 Working Capital Days 34 -37 34 43 34 ROCE -16% -30% -25% -10% 21%